More articles from Hot Topics

You have access
Training Requirements for Theranostics: A Unique Opportunity for Collaboration
Michael M. Graham and John M. Buatti

Journal of Nuclear Medicine September 1, 2019, 60 (9) 1205-1206; DOI: https://doi.org/10.2967/jnumed.119.228940
You have access
Artificial Intelligence in Nuclear Cardiology
Javier Gomez and Rami Doukky

Journal of Nuclear Medicine August 1, 2019, 60 (8) 1042-1043; DOI: https://doi.org/10.2967/jnumed.118.222356
You have access
Imaging of CAR T-Cells in Cancer Patients: Paving the Way to Treatment Monitoring and Outcome Prediction
Simone Krebs, Vladimir Ponomarev, Susan Slovin and Heiko Schöder

Journal of Nuclear Medicine July 1, 2019, 60 (7) 879-881; DOI: https://doi.org/10.2967/jnumed.119.227561
You have access
Imaging the Molecular Footprints of the Heart–Brain Axis in Cardiovascular Disease
James T. Thackeray

Journal of Nuclear Medicine June 1, 2019, 60 (6) 728-729; DOI: https://doi.org/10.2967/jnumed.118.222315
You have access
Continuing Board Certification: Vision for the Future
George M. Segall

Journal of Nuclear Medicine May 1, 2019, 60 (5) 585-586; DOI: https://doi.org/10.2967/jnumed.119.225888
You have access
Entering the Era of Molecularly Targeted Precision Surgery in Recurrent Prostate Cancer
Tobias Maurer, Fijs W.B. van Leeuwen, Margret Schottelius, Hans-Jürgen Wester and Matthias Eiber

Journal of Nuclear Medicine February 1, 2019, 60 (2) 156-157; DOI: https://doi.org/10.2967/jnumed.118.221861
You have access
The Network Degeneration Hypothesis: Spread of Neurodegenerative Patterns Along Neuronal Brain Networks
Alexander Drzezga

Journal of Nuclear Medicine November 1, 2018, 59 (11) 1645-1648; DOI: https://doi.org/10.2967/jnumed.117.206300
You have access
Assessment of the Right-to-Try Law: The Pros and the Cons
Brandon Brown, Camerin Ortiz and Karine Dubé

Journal of Nuclear Medicine October 1, 2018, 59 (10) 1492-1493; DOI: https://doi.org/10.2967/jnumed.118.216945
Open Access
Oligometastatic Prostate Cancer: Molecular Imaging and Clinical Management Implications in the Era of Precision Oncology
Hossein Jadvar

Journal of Nuclear Medicine September 1, 2018, 59 (9) 1338-1339; DOI: https://doi.org/10.2967/jnumed.118.213470
You have access
Salivary Gland Toxicity of PSMA Radioligand Therapy: Relevance and Preventive Strategies
Thomas Langbein, Guillaume Chaussé and Richard P. Baum

Journal of Nuclear Medicine August 1, 2018, 59 (8) 1172-1173; DOI: https://doi.org/10.2967/jnumed.118.214379

Main menu

User menu

Search

More articles from Hot Topics

Pages